Grupo Gallego de Investigación en Oncología de Precisión
ONCOGAL
Hospital Universitario Virgen Macarena
Sevilla, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitario Virgen Macarena (8)
2024
-
First-line therapy with palbociclib in patients with advanced HR+/HER2− breast cancer: The real-life study PALBOSPAIN
Breast Cancer Research and Treatment, Vol. 206, Núm. 2, pp. 317-328
2023
2021
-
Adherence to the Sociedad Española de Oncología Médica (SEOM) Algorithm for the Treatment of Hyponatremia in Oncology Patients in Spain: The ALGA Study
Advances in Therapy, Vol. 38, Núm. 1, pp. 290-303
2019
-
Active study: undetected prevalence and clinical inertia in the treatment of breakthrough cancer pain (BTcP)
Clinical and Translational Oncology, Vol. 21, Núm. 3, pp. 380-390
2018
-
Assessment and treatment of breakthrough cancer pain in Spain: A self-audit study
Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. viii611-viii612
2016
-
SIADH-related hyponatremia in hospital day care units: clinical experience and management with tolvaptan
Supportive Care in Cancer, Vol. 24, Núm. 1, pp. 499-507
2014
-
Social value of a quality-adjusted life year (QALY) in Spain: the point of view of oncologists
Clinical and Translational Oncology, Vol. 16, Núm. 10, pp. 914-920
2010
-
Activity of a multitargeted chemo-switch regimen (sorafenib, gemcitabine, and metronomic capecitabine) in metastatic renal-cell carcinoma: A phase 2 study (SOGUG-02-06)
The Lancet Oncology, Vol. 11, Núm. 4, pp. 350-357